Cargando…

Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity

DDX56, a member of the RNA helicase family, is upregulated in colon adenocarcinoma, lung squamous cell carcinoma, and osteosarcoma. However, the relationships between DDX56 and other tumors are not clear, and the molecular mechanism of its action is not fully understood. Here, we explore the biologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Zhaohui, Zhang, Yuetong, Quan, Qi, Jiang, Jiaxin, Wang, Qianyu, Zhang, Yujing, Peng, Roujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768347/ https://www.ncbi.nlm.nih.gov/pubmed/36568395 http://dx.doi.org/10.3389/fgene.2022.1004467

Ejemplares similares

New Staging System and Prognostic Model for Malignant Phyllodes Tumor Patients without Distant Metastasis: A Development and Validation Study
por: Ruan, Zhaohui, et al.
Publicado: (2023)

DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC
por: Sun, Yang, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological roles of DEAD-box helicase 5 (DDX5) in human tumors
por: Liu, Shixuan, et al.
Publicado: (2022)

Development and validation of a prognostic model and gene co-expression networks for breast carcinoma based on scRNA-seq and bulk-seq data
por: Ruan, Zhaohui, et al.
Publicado: (2022)

SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration: A Pan-Cancer Analysis
por: Wang, Yu, et al.
Publicado: (2022)

An immune and epithelial–mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas
por: Luo, Wei, et al.
Publicado: (2023)

A comprehensive prognostic and immune infiltration analysis of EXOC3L1 in pan-cancer
por: Zhang, Zhan-Fei
Publicado: (2022)

Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
por: Schwartz, Gregory W., et al.
Publicado: (2018)

Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates
por: Wei, Qin, et al.
Publicado: (2022)

Identifying LATS2 as a prognostic biomarker relevant to immune infiltrates in human esophageal squamous cell carcinoma
por: Zhu, Minqi, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic Targets
por: Qu, Yi-Yuan, et al.
Publicado: (2021)

Human DDX56 protein interacts with influenza A virus NS1 protein and stimulates the virus replication
por: Pirinçal, Ayşegül, et al.
Publicado: (2021)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023)

Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers
por: Zhu, Dong, et al.
Publicado: (2023)

Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration
por: Hu, Pengbo, et al.
Publicado: (2022)

DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
por: Yuan, Mengping, et al.
Publicado: (2022)

Pan-cancer analysis reveals NAA50 as a cancer prognosis and immune infiltration-related biomarker
por: Fang, Tao, et al.
Publicado: (2022)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
por: Tang, Sheng, et al.
Publicado: (2022)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

DDX56 Binds to Chikungunya Virus RNA To Control Infection
por: Taschuk, Frances, et al.
Publicado: (2020)

PanSVR: Pan-Genome Augmented Short Read Realignment for Sensitive Detection of Structural Variations
por: Li, Gaoyang, et al.
Publicado: (2021)

ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis
por: Ning, Yijie, et al.
Publicado: (2023)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
por: Zhang, Chi, et al.
Publicado: (2022)

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors
por: Zhao, Huihui, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

INHBA is a Prognostic Biomarker and Correlated With Immune Cell Infiltration in Cervical Cancer
por: Zhao, Kaidi, et al.
Publicado: (2022)

PER1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Ovarian Cancer
por: Chen, Mali, et al.
Publicado: (2021)

Prognostic and immunological role of SERPINH1 in pan-cancer
por: Zhong, Huage, et al.
Publicado: (2022)

INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer
por: Yu, Weifeng, et al.
Publicado: (2022)

Prognostic Biomarker KIF18A and Its Correlations With Immune Infiltrates and Mitosis in Glioma
por: Tao, Bing-Yan, et al.
Publicado: (2022)

A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
por: Yang, Dinglong, et al.
Publicado: (2022)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
por: Xiao, Chen, et al.
Publicado: (2022)

A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts Infiltration
por: Du, Kunpeng, et al.
Publicado: (2022)

Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Fan, Yumei, et al.
Publicado: (2021)

Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma
por: Ren, Huili, et al.
Publicado: (2022)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Zhu, Changyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8lek8sv0jmckn1sjh416c7ale6